These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7598412)

  • 1. Peptic ulcers can now be cured without operation.
    Baron JH
    Ann R Coll Surg Engl; 1995 May; 77(3):168-73. PubMed ID: 7598412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The current role of Helicobacter pylori eradication in clinical practice.
    Hunt RH; Mohamed AH
    Scand J Gastroenterol Suppl; 1995; 208():47-52. PubMed ID: 7777804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of Helicobacter pylori infections in gastric and duodenal ulcers].
    Svestka T
    Cas Lek Cesk; 2003 Aug; 142(8):483-6. PubMed ID: 14626564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An etiologic approach to management of duodenal and gastric ulcers.
    Rex DK
    J Fam Pract; 1994 Jan; 38(1):60-7. PubMed ID: 8289053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptic ulcer recurrence after Helicobacter pylori eradication: a 5-year follow-up study.
    Fujioka T; Uribe RU; Kubota T; Murakami K; Kawasaki H; Nasu M
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S35-8. PubMed ID: 8574733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Peptic ulcer and Helicobacter pylori, diagnosis and therapy].
    Fixa B; Komárková O
    Cas Lek Cesk; 1999 Jun; 138(12):355-8. PubMed ID: 10566201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Helicobacter pylori in peptic ulcer disease.
    O'Connor HJ
    Scand J Gastroenterol Suppl; 1994; 201():11-5. PubMed ID: 8047817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ulcers and gastritis.
    Kashiwagi H
    Endoscopy; 2005 Feb; 37(2):110-5. PubMed ID: 15692925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy.
    Lanas A; Remacha B; Sáinz R; Hirschowitz BI
    Am J Gastroenterol; 2000 Feb; 95(2):513-9. PubMed ID: 10685760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic applications of vagotomy.
    Olbe L
    Yale J Biol Med; 1994; 67(3-4):153-7. PubMed ID: 7502524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of Helicobacter pylori in the etiology of peptic ulcer and its therapy].
    Köksal H
    Mikrobiyol Bul; 1993 Jul; 27(3):266-70. PubMed ID: 8361417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
    J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori and its involvement in gastritis and peptic ulcer formation.
    Konturek SJ; Konturek PC; Konturek JW; Plonka M; Czesnikiewicz-Guzik M; Brzozowski T; Bielanski W
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():29-50. PubMed ID: 17033104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intriguing relationship of Helicobacter pylori infection and acid secretion in peptic ulcer disease and gastric cancer.
    Malfertheiner P
    Dig Dis; 2011; 29(5):459-64. PubMed ID: 22095010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
    Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
    J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori and peptic ulcer disease.
    Van der Hulst RW; Tytgat GN
    Scand J Gastroenterol Suppl; 1996; 220():10-8. PubMed ID: 8898430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection.
    Labenz J; Börsch G
    Am J Gastroenterol; 1994 Oct; 89(10):1785-8. PubMed ID: 7942667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Helicobacter pylori in peptic ulcer disease.
    Partipilo ML; Woster PS
    Pharmacotherapy; 1993; 13(4):330-9. PubMed ID: 8361859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Helicobacter pylori with gastroduodenal diseases.
    Hirai Y; Hayashi S; Shimomura H; Oguma K; Yokota K
    Jpn J Infect Dis; 1999 Oct; 52(5):183-97. PubMed ID: 10680084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
    Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.